Tuesday, January 16, 2018
 
 
Company News: Page (1) of 1 - 10/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing
 
(October 06, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Medicine,healthcare,Therapy,Surgery,Medication,Womens Health,Business,Science,Financial,Lifestyle,Medical,Biology,Adults,Family,Children,Other,Women,
Related Sites: DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • H. Frances Reaves Recognized as a Woman of Excellence by Strathmore's Who's Who Worldwide Publication
  • Sterilization Technology Market is forecasted to grow at a CAGR of 9.0% during 2017-2023
  • Brachytherapy Market Development & Demand, Growth Analysis, Key Findings, Application and Forecast-2027
  • Stent Grafts Market To 2022 - Technological Advancements, EVAR & Rising Demand For Minimally Invasive Procedures To Propel Industry Growth | Million Insights
  • The global dental implant and prosthetic market is expected to reach $9.8 billion by 2022

    Cancer
  • Global Nanotechnology Market Outlook 2024: Market is Expected to Grow at a CAGR of Around 17%
  • The global liquid biopsy market is projected to cross the US$ 5 Billion mark by the end of 2023
  • Marathon Recon: a Mile by Mile Preview of LA’s Largest Marathon
  • RESOLVE: The National Infertility Association Applauds Governor Cuomo For Inclusion Of Infertility Treatments In The 2018 Women's Agenda For New York
  • Beverly A. Huss Joins Accuray Board of Directors
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines